Apixio is the Connected Care Platform at the intersection of health plans and providers. Our actionable AI technology, flexible services, and seamless workflows power accurate payments and high-quality patient care so healthcare organizations can thrive as the industry moves toward value-based reimbursement models.

Led the GTM and portfolio expansion from two to seven solutions for value-based care (risk adjustment, quality, point of care guidance, prior authorization, EHR chart retrieval, bi-directional EHR interoperability).

FDB (First Databank), part of the Hearst Health network, is the leading provider of drug and medical device knowledge that helps healthcare professionals make precise clinical, operational, and financial decisions.Led the GTM market expansion with new products: • Meducation - SMART on FHIR medication adherence SaaS solution for hospitals, pharmacies, care management - available in Epic App Orchard, Cerner code, Allscripts App Store, athenahealth Marketplace; received 2019 Cerner code Program Adoption Award - largest deployment at Dignity Health across 35 hospitals• FDB Targeted Medication Warnings - patient-first medication decision support using lab results, risk scores, and pharmacogenomics• FDB Prizm - medical device database (UDI) for supply chain and clinical use• FDB Pet MedKnowledge - pet medication database for retail pharmacy and payers

• Managed the GTM strategy for Siemens point-of-care and portable ultrasound portfolio globally• Launched ACUSON Freestyle, the first wireless ultrasound system, for point of care and interventional procedures• Experience across clinical specialties (radiology, cardiology, interventional, musculoskeletal, anesthesiology, emergency, sports medicine, pain management)

• Jumpstarted the GTM for Apple-based mobile point-of-care solution integrated to EHRs• 2011 WSJ Top 50 Venture-Backed Companies

Endovascular Innovations - supported the GTM for stent grafts to treat abdominal aortic aneurysms

• Veracyte, Inc. (Molecular Diagnostic) - Team Master's Project - Market Assessment• Theravance, Inc. (Pharmaceutical) - Team Master's Project - Strategic Planning• Independent Study - Best Practices on the Placement of Biotech Manufacturing Facilities in the US and WW

Hematology - Competitive Intelligence - recombinant Factor VIII for hemophilia A patients

Optimized T7 Polymerase Assay

Retained Executive Search for Private Equity firms specific to their portfolio companies

Lab work - synthesis, conjugation, purification